Clinical Evaluation of Efficacy of Kamalanaalkshara in the Management of Grathitaraktapitta W.S.R to Deep Vein Thrombosis

The study was conducted in 45 clinically diagnosed patients of Grathita condition of Raktapitta1,3with respect to deep vein thrombosis. These patients were divided into three groups of 15 patients each as Group A ,Group B, Group C. Patients of group A were recommended injection Heparin 5000 IU 8hrly by intravenous route according to weight and severity of the disease, Patient of group B were administered KamalanaalKshara in the dose of 500mg BD for 30 days with Anupana of Madhu and Ghrita in an unequal quantity and Patients of Group C were recommended with both injection Heparin 5000 IU 8hrly by intravenous route as well KamalanaalKshara in the dose of 500mg BD with Anupana of Madhu and Ghrita in an unequal dose simultaneously. It was observed that the patients of Group C treated with injection Heparin and KamalanaalKshara showed maximum percentage of symptomatic improvement i.e. it showed highly significant values for four parameter whereas in Group B , it was highly significant for 3 parameter, significant for one parameter and that of Group A, it was highly significant for 3 parameters.Present clinical study involved administration of Kshara, so to check out there any subjective disturbance going on, for that author studied the parameters for subjective improvement as in CH.VI.8 (Rogibala Pariksha), they were also found significant.